Immunovia AB Stock London S.E.
Stocks
0G8X
SE0006091997
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.92 SEK | -32.03% |
|
+16,507.70% | +13,658.62% |
| Market Cap | 130M 13.53M 11.83M 10.87M 10.13M 19.22M 1.29B 19.51M 50.73M 633M 50.79M 49.7M 2.18B | P/E 2026 * |
-1.94x | P/E 2027 * | -4.85x |
|---|---|---|---|---|---|
| Enterprise Value | 63.5M 6.58M 5.76M 5.29M 4.93M 9.35M 627M 9.49M 24.68M 308M 24.71M 24.18M 1.06B | EV / Sales 2026 * |
19.8x | EV / Sales 2027 * | 3.27x |
| Free-Float |
89.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Immunovia AB
| 1 day | -32.03% | ||
| 1 week | +16,507.70% | ||
| Current month | +16,370.59% | ||
| 1 month | +14,213.90% | ||
| 3 months | +17,042.86% | ||
| 6 months | +13,961.67% | ||
| Current year | +13,658.62% |
| 1 week | 0.19 |  | 0.32 |
| 1 month | 0.18 | | 0.32 |
| Current year | 0.15 | | 0.32 |
| 1 year | 0.15 | | 0.92 |
| 3 years | 0.15 | | 2.78 |
| 5 years | 0.15 | | 139.14 |
| 10 years | 0.15 | | 292 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | 53 | 2023-04-28 |
Lisa Ford
CTO | Chief Tech/Sci/R&D Officer | 55 | 2024-04-28 |
| Chief Tech/Sci/R&D Officer | 54 | 2024-01-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 2016-12-08 | |
Peter Andersen
CHM | Chairman | 69 | 2023-05-25 |
| Director/Board Member | 51 | 2020-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -32.03% | +16,507.70% | - | - | 13.53M | |
| -1.95% | +1.16% | +3.42% | -29.47% | 16.36B | |
| +5.89% | +23.51% | +46.13% | +98.40% | 1.78B | |
| +0.39% | +32.34% | -39.55% | -78.08% | 1.24B | |
| +0.06% | +3.85% | -28.16% | +33.46% | 1.14B | |
| +1.31% | +4.95% | -25.50% | -53.22% | 640M | |
| +0.21% | +3.42% | -36.59% | -57.01% | 582M | |
| -0.66% | +3.11% | +20.57% | -55.49% | 447M | |
| +1.79% | +0.16% | -55.21% | -60.69% | 382M | |
| +2.52% | +7.65% | -20.43% | -19.03% | 362M | |
| Average | -2.25% | +7.61% | -15.04% | -24.57% | 2.55B | |
| Weighted average by Cap. | -0.83% | +4.51% | +0.01% | -21.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2M 332K 290K 267K 248K 471K 31.59M 478K 1.24M 15.53M 1.25M 1.22M 53.51M | 17.3M 1.79M 1.57M 1.44M 1.34M 2.55M 171M 2.59M 6.73M 83.95M 6.73M 6.59M 289M |
| Net income | -91M -9.44M -8.25M -7.58M -7.07M -13.4M -898M -13.6M -35.38M -442M -35.42M -34.66M -1.52B | -82M -8.5M -7.43M -6.83M -6.37M -12.08M -810M -12.26M -31.88M -398M -31.91M -31.23M -1.37B |
| Net Debt | -67M -6.95M -6.07M -5.58M -5.2M -9.87M -661M -10.02M -26.05M -325M -26.08M -25.52M -1.12B | -74M -7.67M -6.71M -6.16M -5.75M -10.9M -731M -11.06M -28.77M -359M -28.8M -28.18M -1.24B |
Employees
17
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | SEK 0.1938 | +0.83% | 5 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMNOV Stock
- 0G8X Stock
Select your edition
All financial news and data tailored to specific country editions
